Clinical trial

Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

NCT07832942

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-11-01

PhaseNA

Study timeline

Study start (estimated)2026-11-01Date precision: month

Registry last updated2026-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Genetics in Hypertensionunresolved

Interventions

low sodium dietOTHER

high sodium dietOTHER

renal plasma flowPROCEDURE

SIEA collectionPROCEDURE

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07832942 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.